Brief: Julian Singer - On June 15, JDS1 Llc Filed A Complaint In The Delaware Court Of Chancery Against Catalyst Biosciences And Its Directors
June 17 (Reuters) - Catalyst Biosciences Inc CBIO.O :
* JULIAN SINGER - ON JUNE 15, JDS1 LLC FILED A COMPLAINT IN
THE
DELAWARE COURT OF CHANCERY AGAINST CATALYST BIOSCIENCES INC AND
ITS DIRECTORS
* JULIAN SINGER - JDS1 LLC FILED COMPLAINT AGAINST CATALYST
SEEKING DECLARATORY, INJUNCTIVE, AND EQUITABLE RELIEF AND
DAMAGES UNDER CERTAIN DELAWARE LAWS
Further company coverage: CBIO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Gyre Therapeutics
See all newsBrief: Gyre Therapeutics - Enters Employment Agreement With Ying Luo As CEO - SEC Filing
Gyre Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Gyre Therapeutics, Inc. expected to post a loss of 13 cents a share - Earnings Preview
Brief: Gyre Therapeutics Reports Second Quarter 2026
Gyre Therapeutics Q2 revenue beats estimates on higher ETUARY sales volumes